U.S. Drops in Share of Publications

New analysis reveals increased globalization of science, leading to a greater proportion of patents and papers coming out of developing countries.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, TOMWSULCERU.S. researchers continue to produce plenty of academic papers—to the tune of around 350,000 each year, making up nearly 28 percent of the world's share of manuscripts indexed in Thomson Reuters's Web of Science. No other individual country comes close; the entire European Union comprises another 35.5 percent of the pie. But according to Thomson Reuters's latest analysis of G20 countries, released this month, those percentages have been sliding in recent years—despite the absolute numbers of papers holding steady—thanks to upticks in output from China, Indonesia, Saudi Arabia, and South Korea, among others.

“In general, world shares for nations with mature scientific enterprises have declined and those of developing nations have risen,” the authors wrote in their report. China, for instance, has surged from producing around 6 percent of the world's scientific papers in 2003 to 14 percent in 2012.

The study also looked at the number of patents coming out of these countries. “The clearest thing to come out of the study is the shrinking in-country share of patents in 2012 despite the rise in overall number of patents,” Thomson Reuters analyst David Pendlebury told Wired. In other words, the proportion of inventions originating from residents of a country shrunk, while innovations coming from non-resident companies or individuals increased. This was true for the U.S., Japan, Russia, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies